Luminal A breast cancer is defined as estrogen receptor (ER)- and/or progesterone receptor (PR)-positive, HER2-negative, and having low Ki-67 expression, indicating a lower proliferative rate [5]. This evidence concerns the gene PGR and luminal A breast carcinoma.